ZA956989B - Methods for bone healing and fracture repair. - Google Patents

Methods for bone healing and fracture repair.

Info

Publication number
ZA956989B
ZA956989B ZA9506989A ZA956989A ZA956989B ZA 956989 B ZA956989 B ZA 956989B ZA 9506989 A ZA9506989 A ZA 9506989A ZA 956989 A ZA956989 A ZA 956989A ZA 956989 B ZA956989 B ZA 956989B
Authority
ZA
South Africa
Prior art keywords
bone healing
fracture repair
methods
image
hexamethyleneamino
Prior art date
Application number
ZA9506989A
Other languages
English (en)
Inventor
George Joseph Cullinan
Masahiko Sato
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA956989B publication Critical patent/ZA956989B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9506989A 1994-08-22 1995-08-21 Methods for bone healing and fracture repair. ZA956989B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/294,130 US5502074A (en) 1994-08-22 1994-08-22 Benzothiophenes for bone healing and fracture repair

Publications (1)

Publication Number Publication Date
ZA956989B true ZA956989B (en) 1997-02-21

Family

ID=23132010

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9506989A ZA956989B (en) 1994-08-22 1995-08-21 Methods for bone healing and fracture repair.

Country Status (20)

Country Link
US (1) US5502074A (xx)
EP (1) EP0769945B1 (xx)
JP (1) JPH10504578A (xx)
KR (1) KR970705385A (xx)
AT (1) ATE240101T1 (xx)
AU (1) AU701946B2 (xx)
CA (1) CA2198012A1 (xx)
CZ (1) CZ51997A3 (xx)
DE (1) DE69530771T2 (xx)
DK (1) DK0769945T3 (xx)
ES (1) ES2197207T3 (xx)
FI (1) FI970715A (xx)
HU (1) HUT76855A (xx)
IL (1) IL115016A (xx)
MX (1) MX9701332A (xx)
NO (1) NO970785L (xx)
PH (1) PH31620A (xx)
PT (1) PT769945E (xx)
WO (1) WO1996005825A1 (xx)
ZA (1) ZA956989B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856340A (en) 1995-02-28 1999-01-05 Eli Lilly And Company Method of treating estrogen dependent cancers
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
AU5862199A (en) * 1998-09-11 2000-04-03 Michael Raschke Biologically active implants
DK1175433T3 (da) 1999-05-04 2005-09-19 Strakan Int Ltd Androgenglycosider og androgen aktivitet deraf

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
DE4122484A1 (de) * 1991-07-06 1993-01-07 Teves Gmbh Alfred Schaltungsanordnung zur erkennung von radsensordefekten
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
TW303299B (xx) * 1993-07-22 1997-04-21 Lilly Co Eli

Also Published As

Publication number Publication date
IL115016A (en) 1999-09-22
WO1996005825A1 (en) 1996-02-29
PT769945E (pt) 2003-09-30
FI970715A0 (fi) 1997-02-20
FI970715A (fi) 1997-02-20
NO970785D0 (no) 1997-02-20
CZ51997A3 (en) 1997-08-13
CA2198012A1 (en) 1996-02-29
MX9701332A (es) 1997-05-31
HUT76855A (en) 1997-12-29
ES2197207T3 (es) 2004-01-01
DE69530771T2 (de) 2004-03-11
JPH10504578A (ja) 1998-05-06
DK0769945T3 (da) 2003-06-10
AU3409795A (en) 1996-03-14
PH31620A (en) 1999-01-12
EP0769945A1 (en) 1997-05-02
EP0769945A4 (en) 1997-09-03
AU701946B2 (en) 1999-02-11
ATE240101T1 (de) 2003-05-15
EP0769945B1 (en) 2003-05-14
US5502074A (en) 1996-03-26
DE69530771D1 (de) 2003-06-18
IL115016A0 (en) 1995-12-08
NO970785L (no) 1997-02-20
KR970705385A (ko) 1997-10-09

Similar Documents

Publication Publication Date Title
IL115014A0 (en) Methods of inhibiting viral replication
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
MX9701334A (es) Metodos para inhibir la degeneracion de protesis oseas.
ZA956989B (en) Methods for bone healing and fracture repair.
MX9702148A (es) Metodos para inhibir la mitosis endometrial.
MX9701327A (es) Metodos para inhibir el cancer endometrial.
MX9701331A (es) Metodos para mantener los dientes y los huesos bucales.
MX9701359A (es) Metodos para la inhibicion de la hiperplasia endometrial primaria.
GR3030255T3 (en) Methods of reducing scarring in wound healing
MX9709536A (es) Metodo para reducir el factor de transcripcion bef-1.
MX9705215A (es) Uso de 2-fenil-3-aroilbenzotiofenos para inhibir los efectos de la hormona del crecimiento.
MX9709651A (es) Metodos para modulacion del factor de transcripcion nf-kb.
MX9705697A (es) Metodos para reducir los niveles de calcio del suero.
MX9702861A (es) Metodo para inhibir las condiciones asociadas con la bradicinina.
MX9705537A (es) Metodos y composiciones para inhibir el efecto de los estrogenos del medio ambiente.